工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
我们的方法将酶/前药治疗和免疫治疗整合到一个单一的细菌递送系统中,通过提供合理设计的空间控制化学免疫治疗框架,克服了传统疗法的关键局限性。
英文原题:Efficient recovery of potent tumour-infiltrating lymphocytes through quantitative immunomagnetic cell sorting.
过继细胞疗法需要获取并扩增高活性的TIL(肿瘤浸润淋巴细胞)。
过继细胞疗法需要回收并扩增高效力的TIL(肿瘤浸润淋巴细胞)。然而,肿瘤中的TIL稀少且难以高效分离,这阻碍了对治疗效力和剂量的优化。我们展示一种可配置的微流控装置,可利用靶细胞表面标志物的特定表达水平,从实体瘤中高效回收高效力TIL。该装置夹在永磁体之间,通过平衡磁力和流体阻力,对结合了靶标志物抗体的磁性纳米颗粒标记细胞进行分选。与传统细胞分选相比,免疫磁性分选回收的TIL数量最高可增加30倍;回收细胞数量和多样性的提高加快了TIL扩增,并增强其治疗效力。免疫磁性分选还使研究者能够识别和分离高效力TIL亚群,尤其是CD39中等表达的TIL(CD39是T细胞对肿瘤反应性及耗竭的标志物);我们发现这类细胞具有肿瘤特异性、自我更新能力,并且是过继细胞疗法长期成功的关键。
Adoptive cell therapies require the recovery and expansion of highly potent tumour-infiltrating lymphocytes (TILs). However, TILs in tumours are rare and difficult to isolate efficiently, which hinders the optimization of therapeutic potency and dose. Here we show that a configurable microfluidic device can efficiently recover potent TILs from solid tumours by leveraging specific expression levels of target cell-surface markers. The device, which is sandwiched by permanent magnets, balances magnetic forces and fluidic drag forces to sort cells labelled with magnetic nanoparticles conjugated with antibodies for the target markers. Compared with conventional cell sorting, immunomagnetic cell sorting recovered up to 30-fold higher numbers of TILs, and the higher levels and diversity of the recovered TILs accelerated TIL expansion and enhanced their therapeutic potency. Immunomagnetic cell sorting also allowed us to identify and isolate potent TIL subpopulations, in particular TILs with moderate levels of CD39 (a marker of T-cell reactivity to tumours and T-cell exhaustion), which we found are tumour-specific, self-renewable and essential for the long-term success of adoptive cell therapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。